Parliament Workbench

Question thread · 3 questions

In light of the fines issued in the United States to pharmaceutical companies for promoting medicines for uses or age groups not in the licence granted in the EU, what consideration it has given to requiring the collect…

Started with S4W-10963 on 6 Nov 2012; latest 29 Nov 2012. Each later question says it follows up an earlier answer.

Follow-ups
2
longest chain 1 step
Span
23 days
6 Nov 2012 to 29 Nov 2012
Answered
3 of 3
by Alex Neil
Asked by
1
Dr Richard Simpson

The thread, in order

Each answer’s opening lines; open a question for the full text
  1. S4W-10963 6 Nov 2012 Dr Richard Simpson Lab Answered

    To ask the Scottish Government, in light of the fines issued in the United States to pharmaceutical companies for promoting medicines for uses or age groups not in the licence granted in the EU, what consideration it has given to requiring the collection and collation of data related to off-licence prescribing.

    Alex Neil, 21 Nov 2012: The advertising and promotion of medicines in the UK, as well as medicine safety issues, are subject matters of the Human Medicines Regulations 2012 and are currently reserved issues. The promotion of a medicine for use outside the terms of its marketing authorisation is prohibited. Details are available in the UK Med…
  2. S4W-11624 29 Nov 2012 Dr Richard Simpson Lab Answered

    How many patients have been affected by the use of (a) off licence and (b) unlicensed prescription medicines by the NHS in the last two years for which information is available.

    Alex Neil, 13 Dec 2012: As stated in my answer to question S4W-10963, medicine safety issues are subject matters of the Human Medicines Regulations 2012 and are currently reserved issues. The Medicines and Healthcare products Regulatory Agency which is the UK government agency responsible for the regulation of medicinal products and medical …
  3. S4W-11625 29 Nov 2012 Dr Richard Simpson Lab Answered follows S4W-10963

    What steps the Patient Safety Programme is taking to examine any adverse effects of the (a) off licence and (b) unlicensed use of prescription medicines by the NHS.

    Alex Neil, 13 Dec 2012: As stated in my answer to question S4W-10963, medicine safety issues are subject matters of the Human Medicines Regulations 2012 and are currently reserved issues. The Scottish Patient Safety Programme has no plans to examine any adverse effects of the (a) off licence and (b) unlicensed use of prescription medicines b…

How this thread is put together

Follow-up
A question whose text says it is “further to the answer to question …” (or reply, response, or asks for a “substantive answer” to an earlier question). The question it names is its parent.
Several citations
When a question cites more than one earlier question, the most recent one we hold is used as the parent; the others are listed as “also cites”.
Thread
Follow parents back to the first question; every question that leads back to it is in this thread. Branches are shown in date order.

All question threads